#Sweden #Gothenburg #Zinzino #Share Issues #capital increase

ZINZINO AB's Strategic Move: New Share Issues

In a significant development for ZINZINO AB, a leading health and wellness company, the Board of Directors has approved two directed share issues following the authorization from the Annual General Meeting held on May 28, 2025. This decision aims to strengthen the company's capital base and is part of a broader strategy to enhance its market position.

On March 24, 2026, the company announced the issuance of a total of 401,965 new Zinzino B shares as a set-off against claims related to SM Nano-Biotechnology S.A DE C.V. This transaction is directly linked to the previously disclosed acquisition of certain assets and subsidiaries of Sanki, finalized on November 8, 2025.

Additionally, ZINZINO issued 69,621 new Zinzino B shares as a set-off against claims involving Bodē Pro. This issuance connects to the earlier communicated acquisition of Bodē Pro, which took place on September 12, 2025.

These actions increase the total number of B shares in ZINZINO to 33,521,574, resulting in an overall share count of 38,634,966. While this move introduces a dilution of approximately 1.22 percent to the existing shareholders, it is expected to fortify the company's financial standing significantly.

The capital increase reflects a growth in ZINZINO's total share capital by SEK 47,159, raising it from SEK 3,816,338 to SEK 3,863,497. This enhancement is a testament to ZINZINO's commitment to attracting investment and supporting its ongoing growth initiatives.

Context and Implications

The decision to issue new shares reflects ZINZINO's proactive approach to financial management and its ambition to expand its operations. By engaging in strategic partnerships and acquiring complementary businesses, ZINZINO is positioning itself as a formidable contender in the health and wellness market.

CEO Dag Bergheim Pettersen emphasized the importance of these share issues during a recent press release, indicating that such capital maneuvers are essential for funding innovation and expansion endeavors. CFO Fredrik Nielsen also noted that these transactions provide ZINZINO with the necessary resources to leverage growth in a competitive landscape.

Looking Ahead

As ZINZINO moves forward with these new share issues, stakeholders and investors will be keenly observing the company's performance, especially in terms of sales growth and market share. Furthermore, the financial backing from these new shares could enable ZINZINO to further diversify its product offerings and enhance its research and development efforts.

In conclusion, the recent share issues serve not only as a financial strategy but also as a clear indication of ZINZINO AB's dedication to sustaining its growth trajectory while navigating an evolving market. With successful execution of its strategic initiatives, ZINZINO is well-positioned to achieve its long-term objectives.